Search Results
Oct 19, 2025, 00:39 ET From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference
natural extension of Chery's innovation strategy. Technological Foundation: Robotics Grown from Automotive DNA The technology system of AiMOGA Robotics is rooted in Chery's vehicle-engineering platform.
More news about: AiMOGA Robotics
Oct 18, 2025, 10:42 ET Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 17, 2025, 11:51 ET OPPO leva Reno14 à São Paulo Fashion Week e reforça conexão entre tecnologia e criatividade
potencial da marca no universo da moda e da criação de conteúdo. "A SPFW é o maior evento de moda do hemisfério sul e traduz valores que também estão no DNA da OPPO: inovação, criatividade e lifestyle. Participar desse cenário é uma forma de conectar nossa tecnologia ao universo da moda e dialogar com um
More news about: OPPO Brasil
Oct 17, 2025, 11:39 ET A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben
mit einer einzigen Blutentnahme verwertbare genomische Veränderungen nachzuweisen. Er nutzt modernste künstliche Intelligenz, um zirkulierende Tumor-DNA (ctDNA) auf minimalinvasive Weise zu analysieren. Der Test verwendet einen abgestimmten Tumor-Normal-Ansatz, der die Genauigkeit verbessert und falsch-positive
More news about: SOPHiA GENETICS
Oct 17, 2025, 09:37 ET A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan
is ontworpen om bruikbare genoomveranderingen te detecteren vanuit een enkel bloedmonster, waarbij met behulp van geavanceerde AI circulerend tumor-DNA (ctDNA) op een minimaal invasieve manier wordt geanalyseerd. De test maakt gebruik van een gematchte tumor-normaal-benadering die de nauwkeurigheid verbetert
More news about: SOPHiA GENETICS
Oct 17, 2025, 09:00 ET Getac Integrates Semtech AirLink® for Mission-Critical Connectivity
defense, utility, and industrial sectors," said Rick Geisendorff, VP of Sales & Marketing, Getac North America. "Through pairing Getac's rugged DNA with Semtech's cellular technology, customers benefit from always-on connectivity, seamless backup between 5G, LTE, Wi-Fi, and satellite, and support
More news about: Getac
Oct 17, 2025, 09:00 ET Asymmetric Capital Partners Announces $137 Million Fund II to Back Early Stage Founders
concentration, and real operational support. The firm invests in disruptive technology-driven companies in the Pre-seed through Series A stages. Asymmetric's DNA is different by design: its team blends rigorous investing experience with hands-on operating expertise, having built, scaled, and acquired companies
More news about: Asymmetric Capital Partners
Oct 17, 2025, 08:15 ET MEDIA ADVISORY - MDA SPACE TO HOLD ITS THIRD QUARTER 2025 EARNINGS CONFERENCE CALL ON NOVEMBER 14, 2025
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Oct 17, 2025, 02:53 ET MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
/PRNewswire/ -- MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new tumor-informed circulating-tumor DNA (ctDNA) blood test for detecting minimal residual disease (MRD) in patients diagnosed with solid tumor cancers. The HPH MRD test is an in-house test
More news about: Quest Diagnostics
Oct 17, 2025, 00:30 ET Adoor Gopalakrishnan Launches Radha Chadha's 'The Maker of Filmmakers' at FTII Pune, Alongside Eminent Alumni and Filmmakers
as a straightforward story of his life. But pretty soon I realized that I could not tell his story without telling that of FTII. Like twin strands of DNA, they twisted around each other. He made the Institute, the Institute made him." Through her father's journals, Radha discovered a treasure trove of
More news about: Radha Chadha
Oct 16, 2025, 22:06 ET Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
already use." For the pilot project, GeneDx used its fleet of NovaSeq X Plus Systems with constellation kits to evaluate 160 DNA samples from individuals with known genetic disease. GeneDx compared samples run with constellation to orthogonal methods, like long-read sequencing,
More news about: Illumina
Oct 16, 2025, 17:31 ET Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight
Advancements in molecular profiling techniques, such as next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) analysis, have enabled the identification of genetic alterations contributing to disease development and progression. These technologies guide
More news about: DelveInsight Business Research, LLP
Oct 16, 2025, 14:32 ET Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm
Twist's business and operations. Specifically, the Complaint alleges that insiders overstated the commercial viability of Twist's synthetic DNA manufacturing technology while engaging in accounting fraud and using unsustainable pricing to inflate the company's true financial condition
More news about: Kuehn Law, PLLC
Oct 16, 2025, 12:00 ET Roller Rabbit and Mackage Redefine Winter Dressing with Limited-Edition Collaboration
iconic loungewear. "We are truly excited to finally share this partnership that merges Roller Rabbit's joyful DNA with Mackage's mastery of outerwear," said Ed Bertouch, CEO of Roller Rabbit. "Our audience loves the idea of the Roller Rabbit vibrant prints meeting
More news about: Mackage
Oct 16, 2025, 11:00 ET A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
biopsy test is designed to detect actionable genomic alterations from a single blood draw, leveraging state-of-the-art AI to analyze circulating tumor DNA (ctDNA) in a minimally invasive manner. The test utilizes a matched tumor-normal approach which improves accuracy and avoids false positives. By launching
More news about: SOPHiA GENETICS
Oct 16, 2025, 11:00 ET A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
biopsy test is designed to detect actionable genomic alterations from a single blood draw, leveraging state-of-the-art AI to analyze circulating tumor DNA (ctDNA) in a minimally invasive manner. The test utilizes a matched tumor-normal approach which improves accuracy and avoids false positives. By launching
More news about: SOPHiA GENETICS
Oct 16, 2025, 09:48 ET Wireless Zone Enters New Era with the Appointment of Al Pellecchia as Executive Vice President
400 communities, actively invests in local and national causes. Community giveback initiatives are a core part of Round Room and each of its entities' DNA as the company regularly organizes events that leave positive impacts on the communities it serves. On a larger, national scale, they host quarterly initiatives
More news about: Wireless Zone
Oct 16, 2025, 09:33 ET Meet Caravel: Pioneering a New Era of Biotechnology with the First Unified Platform for Protein Discovery and Delivery
distinct markets: DNA synthesis: Caravel and its collaborators will develop a protein to reduce the cost of DNA synthesis, facilitating the development of new cancer therapies, the engineering of microbes for chemical
More news about: Caravel Bio
Oct 16, 2025, 09:30 ET Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Oct 16, 2025, 09:03 ET Milk Makeup Extends Its Roots in Music and Culture
recent collaborations with Jessie Reyez and St. Vincent, Milk continues to connect beauty and culture in ways that feel organic and rooted in the brand's DNA.
More news about: Milk Makeup
Oct 16, 2025, 09:00 ET Mercy Offers New Hereditary Testing for High-Risk Patients
Center for Precision Medicine is launching a new screening tool to identify those at high risk for cancer who may benefit from germline or hereditary DNA testing. Working with genetic testing company Tempus, Mercy is one of the first health systems in the country to launch the screening program widely
More news about: Mercy
Oct 16, 2025, 08:33 ET PAJUNK® Expands U.S. Headquarters in Alpharetta, Georgia
that enhances workflow, comfort, and collaboration. "Engineering excellence and continuous improvement are part of PAJUNK's DNA," added Martin Hauger, Managing Director, PAJUNK Germany. "This expansion reflects our long-term vision for U.S. growth and our commitment to innovation,
More news about: PAJUNK Medical
Oct 16, 2025, 08:00 ET Broad Clinical Labs Sets New GUINNESS WORLD RECORDS™ Title for Fastest DNA Sequencing Technique
Roche Sequencing Solutions and Boston Children's Hospital, today announced official recognition by Guinness World Records for achieving the fastest DNA sequencing technique to date. Leveraging Roche's new SBX sequencing technology1 and a streamlined, integrated workflow, the teams completed
More news about: Broad Clinical Labs
Oct 16, 2025, 08:00 ET Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston
ALS, Alzheimer's disease, and Parkinson's disease. The Company's current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. Klotho is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical
More news about: Klotho Neurosciences, Inc.
Oct 15, 2025, 23:53 ET Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
a successful early-access program. Illumina 5-Base DNA Prep offers whole-genome coverage and Illumina 5-Base DNA Prep with Enrichment allows the user to focus on select genomic regions of interest through targeted enrichment. Both kits can detect DNA methylation at a single-base resolution.
More news about: Illumina